TOVX
Theriva Biologics, Inc.
$0.23
-0.01 (-5.31%)
At close · Jul 16
Market Cap
$10.48M
Shares
45,892,668
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-07 | — | |
| DEF 14A | 2026-06-29 | 2026-08-03 | |
| 8-K | 2026-06-11 | — | |
| 8-K | 2026-06-05 | — | |
| 8-K | 2026-05-05 | — | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| DEF 14A | 2026-04-30 | 2026-06-05 | |
| 8-K | 2026-04-17 | — | |
| 8-K | 2026-04-09 | — | |
| 8-K | 2026-03-23 | — | |
| DEF 14A | 2026-03-16 | 2026-04-09 | |
| 8-K | 2026-03-12 | — | |
| 10-K | 2026-03-12 | 2025-12-31 | |
| 8-K | 2026-02-18 | 2026-02-17 | |
| 8-K | 2026-02-12 | 2026-02-11 | |
| 8-K | 2026-01-12 | — | |
| DEF 14A | 2026-01-05 | 2026-02-11 | |
| 8-K | 2025-12-29 | — | |
| 8-K | 2025-12-15 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-12 | — | |
| DEF 14A | 2025-11-10 | 2025-12-15 | |
| 8-K | 2025-10-29 | — | |
| 8-K | 2025-10-24 | — | |
| 8-K | 2025-10-20 | — | |
| 8-K | 2025-10-17 | 2025-10-16 | |
| 8-K | 2025-10-14 | 2025-10-13 | |
| 8-K | 2025-10-08 | — | |
| 8-K | 2025-10-06 | — | |
| 8-K | 2025-10-02 | 2025-09-28 | |
| 8-K | 2025-09-04 | 2025-08-29 | |
| 8-K | 2025-08-11 | — | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| DEF 14A | 2025-07-09 | 2025-08-29 | |
| 8-K | 2025-06-25 | — | |
| 8-K | 2025-06-20 | — | |
| 8-K | 2025-06-02 | 2025-05-27 | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-14 | — | |
| 8-K | 2025-05-08 | 2025-05-07 | |
| 8-K | 2025-05-07 | — | |
| 8-K | 2025-03-31 | — | |
| 8-K | 2025-03-06 | — | |
| 10-K | 2025-03-06 | 2024-12-31 | |
| 8-K | 2024-12-05 | — | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-01 | 2024-10-31 | |
| 8-K | 2024-10-16 | — | |
| 8-K | 2024-10-03 | — |
Showing 1–50 of 172 filings